bacillu
calmetteguerin
bcg
vaccin
provid
protect
tuberculosi
tb
propos
provid
protect
nontb
infecti
diseas
outbreak
result
infect
novel
coronaviru
declar
pandem
march
th
queri
whether
bcg
vaccin
offer
protect
infect
observ
countri
current
univers
bcg
vaccin
polici
significantli
lower
incid
countri
never
univers
bcg
polici
one
past
howev
popul
densiti
median
age
tb
incid
urban
popul
significantli
test
rate
also
connect
bcg
polici
could
potenti
confound
analysi
limit
analysi
countri
high
test
rate
defin
greater
test
per
million
inhabit
paramet
longer
statist
associ
bcg
polici
analyz
countri
high
test
rate
longer
signific
associ
number
case
per
million
inhabit
bcg
vaccin
polici
although
preliminari
analys
indic
bcg
vaccin
may
offer
protect
infect
report
bias
may
confound
observ
find
support
exercis
caution
determin
potenti
correl
bcg
vaccin
incid
part
due
significantli
lower
rate
test
per
million
inhabit
countri
current
univers
bcg
vaccin
polici
right
reserv
reus
allow
without
permiss
authorfund
grant
medrxiv
licens
display
preprint
perpetu
sinc
earli
use
bacillu
calmetteguerin
bcg
vaccin
implement
sever
countri
prevent
tuberculosi
tb
diseas
caus
mycobacterium
tuberculosi
infect
mycobacterium
tuberculosi
primarili
impact
lung
function
may
lead
tbrelat
death
vaccin
consist
exposur
tuberculosisrel
live
attenu
mycobacterium
bovi
strain
bcg
vaccin
thu
offer
partial
possibl
variabl
immun
tb
offtarget
effect
also
link
protect
infecti
diseas
evid
previou
outbreak
support
hypothesi
bcg
vaccin
protect
rna
dna
viral
infect
herp
influenza
diseas
asthma
observ
given
support
possibl
bcg
vaccin
provid
protect
infect
novel
coronaviru
sar
infect
result
diseas
known
associ
fever
sever
respiratori
ill
declar
pandem
march
th
april
th
countri
around
globe
report
case
countri
high
tb
incid
children
receiv
bcg
vaccin
earli
infanc
countri
implement
univers
bcg
vaccin
polici
countri
tb
incid
drop
polici
amend
stop
univers
bcg
vaccin
group
categor
report
univers
bcg
polici
past
countri
never
univers
bcg
polici
reason
vaccin
due
low
tb
incid
possibl
retain
use
tuberculin
skin
test
order
assess
current
tb
infect
countri
activ
bcg
vaccin
program
variabl
protect
tb
could
due
differ
bcg
strain
use
vaccin
synthesi
vaccin
batch
differ
time
vaccin
previou
exposur
mycobacterium
distinct
host
haplotyp
bcg
vaccin
may
offer
protect
long
year
post
vaccin
previous
report
norway
possibl
long
year
report
american
indian
alaska
nativ
particip
bcg
vaccin
trial
consider
potenti
protect
bcg
vaccin
infecti
diseas
includ
infect
australia
discontinu
univers
bcg
vaccin
current
test
whether
bcg
vaccin
protect
healthcar
worker
infect
reduc
symptom
clinicaltrialsgov
studi
investig
whether
bcg
vaccin
correl
report
case
mortal
collect
inform
bcg
vaccin
polici
bcg
strain
tb
incid
across
countri
bcg
world
atla
http
wwwbcgatlasorg
analysi
countri
past
bcg
vaccin
polici
countri
year
bcg
introduc
stop
includ
data
israel
show
chang
polici
specifi
cessat
therefor
exclud
analysi
bcg
world
atla
last
updat
data
total
case
new
case
first
report
case
mortal
test
rate
countri
obtain
april
th
use
http
wwwworldometersinfocoronaviru
total
popul
popul
densiti
populationkm
net
migrant
median
age
obtain
http
wwwworldometersinfoworldpopulationpopulationbycountri
percent
femal
popul
obtain
http
ourworldindataorggraphersharepopulationfemal
rate
smoker
obtain
http
ourworldindataorgsmok
heart
diseaserel
mortal
obtain
http
world
map
gener
use
http
mapchartnetworldhtml
variabl
znormal
equival
scale
p
valu
correct
use
benjamini
hochberg
procedur
univari
comparison
bcg
vaccin
bcg
vac
treat
continu
variabl
never
univers
bcg
polici
univers
bcg
polici
past
current
univers
bcg
polici
comparison
countri
limit
test
rate
test
per
million
greater
specifi
result
april
th
countri
around
world
report
case
among
countri
confirm
case
use
confirm
case
cutoff
ascertain
whether
incid
associ
mortal
correl
bcg
vaccin
polici
three
countri
bahrain
serbia
iceland
inform
vaccin
polici
remain
countri
tabl
countri
never
univers
bcg
polici
never
univers
gcg
polici
figur
belgium
netherland
canada
itali
lebanon
unit
state
america
current
never
univers
bcg
polici
yet
countri
may
offer
vaccin
high
risk
subgroup
healthcar
profession
children
parent
high
risk
countri
analyz
countri
univers
bcg
polici
past
includ
mani
european
countri
australia
ecuador
israel
univers
bcg
polici
past
figur
countri
current
univers
bcg
vaccin
polici
includ
countri
central
america
south
america
africa
asia
current
univers
bcg
polici
figur
number
total
case
cutoff
three
group
shown
figur
number
case
per
million
inhabit
significantli
reduc
countri
current
univers
bcg
polici
compar
countri
neveror
pastunivers
bcg
polici
figur
percent
mortal
per
total
case
significantli
reduc
countri
current
past
univers
bcg
polici
compar
countri
never
univers
bcg
polici
figur
f
analys
howev
indic
factor
may
confound
result
includ
popul
densiti
median
age
tb
incid
test
rate
urban
popul
follow
analys
address
potenti
confound
next
follow
paramet
assess
univari
analysi
popul
densiti
populationkm
b
sex
ratio
femal
male
inhabit
c
heartassoci
mortal
percent
smoker
e
percent
urban
popul
f
percent
migrant
g
age
h
rate
diagnost
test
treat
nation
bcg
vaccin
polici
monoton
increas
continu
variabl
never
bcg
prior
bcg
current
bcg
univari
regress
analysi
nation
show
percent
urban
popul
percent
migrant
age
rate
test
confound
analysi
figur
correl
specif
test
bcg
polici
robust
pearson
p
figur
similar
strong
neg
relationship
observ
percent
mortal
test
rate
p
figur
test
rate
significantli
differ
countri
distinct
bcg
vaccin
polici
oneway
anova
p
nonoverlap
valu
differ
countri
differ
bcg
polici
preclud
robust
multivari
analysi
account
subsequ
analysi
includ
high
test
countri
test
per
million
n
current
univers
bcg
vaccin
polici
univers
bcg
vaccin
polici
past
never
univers
bcg
vaccin
polici
result
equival
distribut
test
rate
across
countri
differ
bcg
polici
oneway
anova
p
compar
countri
high
test
current
univers
bcg
polici
longer
significantli
associ
reduc
number
right
reserv
reus
allow
without
permiss
authorfund
grant
medrxiv
licens
display
preprint
perpetu
copyright
holder
preprint
peerreview
http
doi
medrxiv
preprint
case
per
million
figur
number
case
per
million
significantli
lower
countri
current
univers
bcg
polici
low
test
rate
figur
mortal
rate
high
test
countri
signific
reduct
countri
current
bcg
vaccin
polici
differ
observ
countri
current
bcg
vaccin
polici
low
test
rate
figur
univari
regress
analysi
number
case
per
million
hightest
nation
indic
test
rate
percent
heart
death
urban
popul
remain
signific
covari
figur
though
none
significantli
differ
base
nation
vaccin
polici
oneway
anova
p
valu
respect
univari
regress
percent
mortal
high
test
nation
reveal
signific
covari
figur
distinct
supplier
bcg
vaccin
correl
number
case
mortal
larg
scarciti
avail
data
figur
analys
also
confirm
associ
implement
univers
bcg
polici
countri
high
tb
incid
figur
countri
univers
bcg
polici
past
year
polici
discontinu
avail
countri
group
number
case
per
inhabit
significantli
differ
compar
countri
discontinu
univers
polici
least
year
countri
discontinu
univers
polici
less
year
ago
figur
mortal
associ
impact
whether
polici
univers
bcg
vaccin
discontinu
less
year
ago
figur
countri
current
univers
bcg
polici
avail
data
correl
observ
total
case
per
inhabit
percent
mortal
per
total
case
time
sinc
implement
univers
bcg
polici
figur
also
signific
correl
observ
percent
mortal
per
total
case
time
sinc
first
confirm
case
countri
never
univers
bcg
polici
figur
univers
bcg
polici
past
figur
current
univers
bcg
polici
figur
independ
analysi
case
per
million
inhabit
countri
stratifi
base
preval
bcg
vaccin
univers
vaccin
polici
show
priori
correl
current
univers
bcg
vaccin
polici
lower
incid
infect
relat
death
howev
note
test
rate
test
per
million
inhabit
posit
correl
incid
infect
take
consider
import
bia
curat
data
compar
number
case
amongst
countri
distinct
univers
bcg
polici
base
high
test
rate
defin
test
per
million
inhabit
result
show
lack
signific
differ
incid
case
countri
current
univers
bcg
vaccin
polici
countri
neveror
pastunivers
bcg
vaccin
polici
variabl
test
includ
popul
densiti
percent
urban
popul
percent
migrant
median
age
sex
time
sinc
first
confirm
case
percent
smoker
heart
associ
mortal
urban
popul
median
age
significantli
associ
increas
number
case
howev
impact
signific
test
rate
interestingli
associ
mortal
decreas
countri
current
univers
bcg
vaccin
polici
similar
test
rate
may
howev
reflect
potenti
inaccuraci
report
mortal
due
lack
test
studi
limit
sever
critic
consider
address
includ
variabl
inaccuraci
report
posit
case
report
specif
mortal
associ
infect
lack
report
asymptomat
minim
symptomat
case
impact
social
econom
barrier
access
care
associ
comorbid
adher
access
vaccin
per
polici
regard
recent
report
show
correl
univers
bcg
vaccin
polici
number
case
control
incom
studi
howev
take
consider
test
rate
also
possibl
lower
rate
test
combin
lower
viral
load
tradit
warmer
countri
higher
incid
tuberculosi
could
impact
observ
although
studi
host
haplotyp
may
also
inform
incid
case
final
time
sinc
first
exposur
rate
well
popul
adher
social
distanc
measur
may
also
influenc
evolv
data
collect
date
social
distanc
remain
critic
slow
number
new
case
time
data
australian
clinic
test
current
underway
assess
whether
bcg
vaccin
may
protect
clinicaltrialsgov
like
shed
light
possibl
use
bcg
decreas
infect
associ
mortal
figur
distribut
case
mortal
bcg
vaccin
polici
implement
tb
incid
per
inhabit
shown
mean
sem
three
group
bcg
polici
never
red
past
green
current
blue
bcg
vaccin
polici
oneway
anova
kruskalw
perform
b
total
case
per
inhabit
left
panel
percent
mortal
per
total
case
right
panel
shown
mean
sem
countri
univers
bcg
polici
past
discontinu
polici
year
ago
year
ago
mannwhitney
test
perform
c
correl
graph
total
number
case
per
inhabit
left
panel
percent
mortal
per
total
case
right
panel
year
univers
bcg
polici
introduc
e
f
correl
graph
show
percent
mortal
per
total
case
time
sinc
first
confirm
case
day
countri
never
univers
bcg
polici
univers
bcg
polici
past
e
current
univers
bcg
polici
f
signific
ns
p
p
p
countri
rank
highest
lowest
base
percent
mortal
per
total
case
total
case
inhabit
